| Product Name | MF | CAS | Details |
|---|
| Glycocholic Acid Sodium Salt | C26H42NNaO6 | 863-57-0 | Details |
| Lovastatin EP Impurity C | C24H34O4 | 109273-98-5 | Details |
| Levalbuterol Impurity E | C15H25NO3 | 754926-25-5 | Details |
| Nintedanib Impurity G | Details |
| Rilpivirine Impurity 1 | C18H12N6 | 1629023-90-0 | Details |
| 6-(piperazin-1-yl)-4-(o-tolyl)nicotinamide | Details |
| Cefixime Impurity 11 | C16H15N5O8S2 | 1335555-87-7 | Details |
| Fulvestrant Impurity I | C6H8N2 | 1603-41-4 | Details |
| Alogliptin Impurity BOC | C23H29N5O4 | 1618644-31-7 | Details |
| Buspirone EP Impurity B | C12H19ClN4 | 81461-72-5 | Details |
| Sitagliptin Impurity 45 | C4H2ClF3N2O | 723286-98-4 | Details |
| Raloxifene EP Impurity C | C28H27NO5S | 195454-31-0 | Details |
| Teriflunomide Impurity 2 | C9H6F3NO3 | 69066-42-8 | Details |
| 9-((1,3-dioxolan-2-yl)methyl)-1,3-dimethyl-1H-purine-2,6(3H,9H)-dione | C11H14N4O4 | 1174289-18-9 | Details |
| Netupitant Impurity 8 | C30H32F6N4O2 | 910808-12-7 | Details |
| 4-methyl-N-(3-(2-methyl-1H-imidazol-1-yl) | C28H22F3N7O | 641571-05-3 | Details |
| Ibrutinib Impurity 24 | C22H22N6O | 1642630-12-3 | Details |
| N,N'-((2Z,2'Z)-disulfanediylbis | Details |
| Eliglustat Impurity 2 | C23H36N2O5 | 2137145-62-9 | Details |
| Loperamide EP Impurity C | C11H14ClNO | 39512-49-7 | Details |
| Dexamethasone EP Impurity E | C22H28O4 | 13209-41-1 | Details |
| Lopinavir EP Impurity A | C27H38N4O3 | 192726-05-9 | Details |
| Buspirone EP Impurity A | C8H12N4 | 20980-22-7 | Details |
| Nintedanib impurity 38 | C10H14O3 | 58378-33-9 | Details |
| ethyl 3-(dimethylamino)-2-(4-methoxyphenyl) | C14H21NO3 | 323176-93-8 | Details |
| (8S,9S,10R,13S,14S,16R,17R) | C22H28O5 | 2036-77-3 | Details |
| Saxagliptin Impurity 1 | C6H10N2O | 1564266-73-4 | Details |
| Macitentan Impurity 1 | C16H13Br2N5O2 | 1433875-21-8 | Details |
| N-(3-(1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl) | C27H20F3N7O | 2119583-26-3 | Details |
| (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex | C20H28O2 | 5300-03-8 | Details |
| Doxazosin EP Impurity B(Hydrochloride) | C13H17ClN2O3 | 70918-74-0 | Details |
| Details |
| N-Desmethyl Ribociclib | C22H28N8O | 1211441-59-6 | Details |
| N-(3-guanidino-4-methylphenyl) | Details |
| Delamanid Impurity 1 | Details |
| Domperidone Impurity 2 | C14H20ClN3O2 | 53786-45-1 | Details |
| Sorafenib IMpurity A | C13H13N3O2 | 284462-37-9 | Details |
| Sitagliptin Impurity 46 | C6H7F3N4.ClH | 762240-92-6 | Details |
| Noradrenaline Impurity 49 | C15H16FN3O3 | 103222-12-4 | Details |
| Loperamide EP Impurity A | C35H37ClN2O2 | 1391052-94-0 | Details |
| bis(1-(3-((ethoxycarbonyl)amino)- | Details |
| Lovastatin EP Impurity F | C24H34O5 | 1048973-04-1 | Details |
| Efinaconazole Impurity 2 | C10H10F2O2 | 126918-35-2 | Details |
| Nebilolol impurity 46 | C18H20FNO2 | 1029684-20-5 | Details |
| Doxercalciferol Impurity 2 | C28H44O3 | 60133-18-8 | Details |
| Thiothixene | C23H29N3O2S2 | 5591-45-7 | Details |
| Fluticasone IMpurity 13 | C25H31F3O5S | Details |
| Lamivudine Impurity 9 | C4H8O2S2 | 40018-26-6 | Details |
| Mirabegron Impurity 14 | C16H20N2O | 391901-45-4 | Details |
| Levothyroxine EP Impurity B | C15H11ClI3NO4 | 1628720-66-0 | Details |
| Sitagliptin Impurity 51 | C13H12F3NO3 | 1234321-81-3 | Details |
| Eliglustat Impurity 1 | C23H30N2O4 | 491833-27-3 | Details |
| Ibrutinib Impurity 42 | C6H6O3 | 2051-76-5 | Details |
| Fosaprepitant iMpurity 1 | Details |
| 7-methyl-3,4-dihydropyrimido | Details |
| Domperidone Impurity 1 | C14H18ClN3O4 | 53786-44-0 | Details |
| Deubutafrazine Impurity | C6H7NO | 1003-68-5 | Details |
| (2Z,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex | C20H28O2 | 3555-80-4 | Details |
| Sumatriptan EP Impurity A | C27H37N5O2S | 545338-89-4 | Details |
| Nintedanib impurity A | Details |
| Sitagliptin Impurity 42 | C6H7F3N4 | 486460-21-3 | Details |
| Benidipine Impurity E | C17H16N2O6 | 76258-20-3 | Details |
| Lamivudine Impurity 11 | C18H27N3O4S | 147027-10-9 | Details |
| Ciprofloxacin Impurity 7 | C17H22N2O10S2 | 83327-21-3 | Details |
| Venlafaxine EP Impurity C HCl | C15H24ClNO2 | 130198-05-9 | Details |
| Efinaconazole Impurity 1 | C12H13F2N3O2 | 135270-11-0 | Details |
| Bictegravir | C21H18F3N3O5 | 1611493-60-7 | Details |
| Mupirocin EP iMpurity A | C26H44O9 | Details |
| Ibrutinib Impurity 39 | C16H12N4O | 1881246-01-0 | Details |
| Clindamycin phosphate EP Impurity N | Details |
| 2-((8S,10S,13S,14S,16R,17R)-17 | C24H30O5 | 10106-41-9 | Details |
| Phthalamic Acid | C6H9F3N4O | 763105-70-0 | Details |
| Enrofloxacin EP Impurity F | C18H22FN3O | 131775-99-0 | Details |
| (8S,9R,10S,11S,13S,14S,16R,17R) | C22H31FO5 | 426-17-5 | Details |
| Cefixime Impurity 9 | C17H17N5O7S2 | 88621-01-6 | Details |
| 1-chloro-3-(dimethoxymethyl)benzene | C9H11ClO2 | 3395-80-0 | Details |
| Sitagliptin Impurity 43 | C4H3ClN2 | 14508-49-7 | Details |
| Lamivudine Impurity 8 | C10H20O | 2216-51-5 | Details |
| (8S,9R,10S,11S,13S,14S,16S,17R) | C22H29FO5 | 378-44-9 | Details |
| Clindamycin phosphate EP Impurity K | Details |
| Proxyphylline EP Impurity D | C10H14N4O3 | 603-00-9 | Details |
| Nintedanib impurity 35 | C10H9NO4 | 1895918-24-7 | Details |
| Diltiazem Impurity 2 | C22H26N2O4S | 111188-70-6 | Details |
| Vitamin B6 | C8H11NO3 | 65-23-6 | Details |
| 3-(4-(2-(azepan-1-yl)ethoxy)benzyl) | C15H23NO2 | Details |
| Levothyroxine Impurity C | C14H9I3O4 | 51-24-1 | Details |
| Leflunomide Impurity D | C5H5NO3 | 42831-50-5 | Details |
| 2-((R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R) | C26H43NO6 | 475-31-0 | Details |
| Etonogestrel Impurity 1 | C22H28O3 | 215252-94-1 | Details |
| Lovastatin EP Impurity E | C24H38O5 | 77517-29-4 | Details |
| (4R,4aR,5S,6S,12aS)-4-(dimethylamino)- | C22H24N2O8 | 97583-08-9 | Details |
| Vilanterol Impurity 1 | C13H15NO4 | 452340-96-4 | Details |
| Sitagliptin Impurity 48 | C16H19F5N5O5P | 1345822-86-7 | Details |
| Buspirone EP Impurity C | C20H30N8 | 257877-45-5 | Details |
| Mirabegron Impurity 12 | C21H24N4O2S | 1684452-80-9 | Details |
| Nebivolol Impurity 2 | 920275-19-0 | Details |
| Ibrutinib Impurity 17 | C26H28N6O3 | 2031255-26-0 | Details |
| Sitagliptin Impurity 41 | C4H6N4 | 54608-52-5 | Details |
| 2-((8S,9R,10S,11S,13S,14S,16R,17R) | C24H31FO6 | 1177-87-3 | Details |
| Lamivudine Impurity 6 | C14H24O4S | 147126-62-3 | Details |
| Product Total： Product Page： | ||||
| 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 | ||||